MannKind on hold by Jefferies

Jefferies & Co., Inc. analyst Adam Walsh rated MannKind Corp. at hold on expectations of a partnership deal for TI. The company reported second-quarter loss per share of $1.10, $0.25 below Jefferies' estimate and $0.19 below Street consensus. Shares of the Valencia, Calif.-based biopharmaceutical company were up 10 cents, or 0.54%, at $18.48, on volume of 295,655 shares versus the three-month running average of 307,475 shares. (Nasdaq: MNKD)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.